Circulating cytokines and small molecules follow distinct expression patterns in acute myeloid leukaemia-Reference-Cited by-同舟云学术

Circulating cytokines and small molecules follow distinct expression patterns in acute myeloid leukaemia

Published:2017-09-12 Issue:10 Volume:117 Page:1551-1556
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Islam Mirazul,Mohamed Elsa Haniffah,Esa Ezalia,Kamaluddin Nor Rizan,Zain Shamsul Mohd,Yusoff Yuslina Mat,Assenov Yassen,Mohamed Zahurin,Zakaria Zubaidah

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2017316.pdf

Reference20 articles.

1. Brenner AK, Tvedt THA, Nepstad I, Rye KP, Hagen KM, Reikvam H, Bruserud Ø (2017) Patients with acute myeloid leukemia can be subclassified based on the constitutive cytokine release of the leukemic cells; the possible clinical relevance and the importance of cellular iron metabolism. Expert Opin Ther Targets 21 (4): 357–369.

2. Bruserud Ø, Ryningen A, Olsnes AM, Stordrange L, Øyan AM, Kalland KH, Gjertsen BT (2007) Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells. Haematologica 92 (3): 332–341.

3. Cancer Genome Atlas Research Network (2013) Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 368 (22): 2059–2074.

4. Carey A, Edwards DK, Eide CA, Newell L, Traer E, Medeiros BC, Pollyea DA, Deininger MW, Collins RH, Tyner JW (2017) Identification of interleukin-1 by functional screening as a key mediator of cellular expansion and disease progression in acute myeloid Leukemia. Cell Rep 18 (13): 3204–3218.

5. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100 (1): 57–70.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrophage Migration Inhibitory Factor (MIF) and D-Dopachrome Tautomerase (DDT): Pathways to Tumorigenesis and Therapeutic Opportunities;International Journal of Molecular Sciences;2024-04-29

2. Macrophage migration inhibitory factor blockade reprograms macrophages and disrupts prosurvival signaling in acute myeloid leukemia;Cell Death Discovery;2024-03-28

3. Fabrication of a three-dimensional bone marrow niche-like acute myeloid Leukemia disease model by an automated and controlled process using a robotic multicellular bioprinting system;Biomaterials Research;2023-11-06

4. The Role of CXCR1, CXCR2, CXCR3, CXCR5, and CXCR6 Ligands in Molecular Cancer Processes and Clinical Aspects of Acute Myeloid Leukemia (AML);Cancers;2023-09-14

5. The cytokine network in acute myeloid leukemia;Frontiers in Immunology;2022-09-28